Inhibikase Therapeutics, Inc.
Tim Pigot is an experienced executive in the biopharmaceutical sector, currently serving as the Chief Commercial and Strategy Officer at Inhibikase Therapeutics, Inc. since August 2025. Prior to this role, Tim held the position of President at Pigot Consulting from August 2024 to August 2025, and served as Chief Commercial Officer and Sr. Vice President Commercial at Aerovate Therapeutics, Inc. from June 2021 to August 2024. Tim's earlier experience includes serving as Vice President of Marketing at MyoKardia and as Vice President of US Sales and Marketing Oncology and Sr. Director of Marketing at Gilead Sciences. Tim earned a Bachelor of Science in Management from Binghamton University in January 1992.
This person is not in any teams
This person is not in any offices
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson's disease and drive functional reversal inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.